Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors characterized by abdominal obesity, high blood pressure, atherogenic dyslipidemia, hyperglycemia, and a prothrombotic and proinflammatory state, and it is an important risk factor for the development of atherosclerotic cardiovascular diseases and type-2 diabetes mellitus (DM) (1, 2). Dyslipidemia observed in MetS patients, also known as atherogenic dyslipidemia triad which is characterized by low high-density lipoprotein-cholesterol (HDL-C), high triglyceride (TG), and small dens low-density lipoprotein-cholesterol levels increases in these individuals and is believed to be associated with insulin resistance (3).
INTRODUCTION
Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors characterized by abdominal obesity, high blood pressure, atherogenic dyslipidemia, hyperglycemia, and a prothrombotic and proinflammatory state, and it is an important risk factor for the development of atherosclerotic cardiovascular diseases and type-2 diabetes mellitus (DM) (1, 2) . Dyslipidemia observed in MetS patients, also known as atherogenic dyslipidemia triad which is characterized by low high-density lipoprotein-cholesterol (HDL-C), high triglyceride (TG), and small dens low-density lipoprotein-cholesterol levels increases in these individuals and is believed to be associated with insulin resistance (3) .
Increasing data demonstrate that both fasting and postprandial TG levels are associated with coronary artery diseases (4, 5) . TG levels following an oral glucose tolerance test (OGTT) have been shown to be higher among cases with obesity and insulin resistance associated with metabolic risk factors (6) . In this study, we tested the following hypothesis: TG response, in association with insulin resistance, is higher in MetS patients than in non-MetS patients following carbohydrate loading. To this end, the TG responses of patients with and without MetS following OGTT were compared and the relationship between their post-OGTT TG responses and metabolic risk factors were evaluated.
METHODS
A total of 88 cases (70 females, 18 males) without diabetes aged older than 18 years who were referred to Istanbul Medeniyet University Goztepe Training and Research Hospital Internal medicine Clinic and who were eligible according to the inclusion and exclusion criteria were recruited. Ethics Committee's approval (Date: 01.08.2013, Decision Number: 2013/0036) and written consent from the participants were obtained beforehand, and the Declaration of Helsinki principles were followed throughout the study.
Inclusion Criteria
Impaired fasting glucose levels (fasting glucose level between 100 and 125 mg/dL) or HbA1c levels between 5.7% and 6.4% were used as indicators for OGTT.
Exclusion Criteria
Patients with type-1 or type-2 diabetes or patients using anti-diabetes treatment, patients with chronic liver or renal di- The protocol recommended by The World Health Organization was implemented for OGTT (8) . OGTT 2-hour glucose values of <140 mg/dL were identified as normal glucose tolerance (NGT), 140-199 mg/dL as impaired glucose tolerance (IGT), and ≥200 mg/dL as DM (9) .
Anthropometric Measurements
Blood pressure was measured with an appropriate mercury sphygmomanometer, based on Korotkoff phase I and phase V sounds, on both arms, in a sitting position, following a 10-minute rest at minimum. A 2 nd measurement was made on the arm with the higher blood pressure, with at least 3-minute intervals between the two measurements, after which the mean of the systolic and diastolic blood pressures was recorded. Body weight, waist circumference, and height were measured via standard measurement tools by the same person. Waist circumference was measured with the patient standing and lightly exhaling, at the narrowest area of the waist across the plane crossing between spina iliaca anterior superior and arcus costa. BMI was calculated by dividing the patient's weight in kilograms by their height in meters squared (kg/m 2 ).
Biochemical Measurements
Following a 12-hour fasting, venous blood samples were collected for fasting glucose, insulin, HbA1c, total cholesterol (TC), HDL-C, non-HDL-C, TG, TG/HDL-C, and LDL-C measurements.
OGTT was performed with 75 g of glucose and venous blood samples were collected for 0, 1 and 2-hour glucose, TG, and insulin measurements. These samples collected at the OGTT 0, 1, and 2-hour time points were drawn into gel tubes not containing anticoagulants and were centrifuged for 10 minutes at 2500 g within one hour. Glucose, TG, and insulin analyses in the serum samples were performed simultaneously. Glucose and TG measurements were made using the COBAS 8000 analyzer (Roche Diagnostics GmbH, Germany). Serum insulin levels were measured with the chemiluminescence method using an Access DxI 800 Access analyzer (Beckman Coulter Inc. USA). HOMA-IR, which involves the evaluation of the insulin resistance by using fasting glucose and fasting insulin concentrations, was used to assess insulin resistance and was simply calculated by the following formula: fasting plasma glucose×-fasting insulin/22.5 (10). 
Statistical Analysis

RESULTS
There were 88 non-diabetic cases (70 females, 18 males; mean age: 48.73±9.69 years) included in the study. The MetS group consisted of 51 cases (42 females, 9 males) diagnosed with MetS, while the remaining 37 non-MetS cases (28 females, 9 males) were included in the control group.
The clinical characteristics of the groups are displayed in Table 1 . Age and gender distribution were similar across groups. The frequency of antihypertensive drug use (p=0.001), BMI (p=0.001), waist circumference (p=0.001), systolic blood pressure (p=0.028), TG (p=0.001), insulin (p=0.009), and HOMA-IR (p=0.045) were higher in the MetS group than in the control group, while HDL-C (p=0.001) was lower in the MetS group.
Post-OGTT NGT and IGT were observed in 72.7% (72.5% in the MetS group and 73% in the control group, p>0.05) and 27.3% (27.5% in the MetS group and 27% in the control group, p>0.05) of the cases, respectively.
The changes in glucose and insulin levels during OGTT are presented in Tables 2 and 3 . In both the groups, glucose and insulin levels significantly increased in the 1 st hour compared with the 0 th hour and then significantly decreased in the 2 nd hour compared with the 1 st hour (p=0.001 for both). The changes in TG during OGTT are shown in Table 4 . The OGTT 2-hour TG levels decreased significantly in both the groups compared with the 0-hour and 1-hour levels (p=0.001 for both).
In the MetS group, OGTT 2-hour TG levels were positively correlated with waist circumference (r=0.360, p=0.009), fasting plasma glucose (r=0.358, p=0.009), insulin (r=0.423, p=0.002), and HOMA-IR (r=0.432, p=0.002), while they were negatively correlated with HDL-C (r=−0.517, p=0.001).
DISCUSSION
The results of this study did not support the hypothesis that the TG response, in association with insulin resistance, may be excessive among MetS patients compared to non-MetS patients following carbohydrate loading, and in fact oppositely demonstrated that TG levels significantly decreased. On the other hand, the significant correlation observed between the post-OGTT TG levels of MetS patients and the MetS parameters supports the association between TG and insulin resistance.
While it is still a topic of debate whether hypertriglyceridemia is an independent risk factor for coronary artery disease, increasing evidence shows that postprandial hypertriglyceridemia contributes to the development of atherosclerosis and coronary artery diseases (11, 12) . It is known that coronary artery disease patients have increased excessive postprandial lipemia and increased lipoprotein residue rich in TG (13).
Mixed meals (including various ratios of carbohydrate, fat, and protein) or oral metabolic tests (standard fat solutions) are used in postprandial hypertriglyceridemia evaluation, and both methods demonstrate postprandial plasma triglyceride concentrations may peak about 4 hours after a mixed food meal in normal subjects, but the peak is delayed in subjects with hypertriglyceridemia (14) (15) (16) . On the other hand, it has been demonstrated that obese individuals are more sensitive to hypertriglyceridemia induced by carbohydrates than normal-weight individuals following carbohydrate loading and that post-OGTT plasma TG levels are higher among obese and insulin-resistant cases and are associated with metabolic risk factors (6) . Nevertheless, the TG response of MetS patients to OGTT remains unknown.
It is known that free fatty acids (FFAs) derived from serum TGs increase hepatic glucose production and induce hepatic insulin resistance; hence this may explain the robust association of TGs and FFAs with insulin resistance and glucose (16) . In this study, the hypothesis was tested that the TG response, in association with insulin resistance, may be excessive among MetS patients compared to non-MetS patients following carbohydrate loading. The TG responses of cases with MetS and without MetS were compared. Our results showed that OGTT 2-hour TG levels significantly decreased in both groups, thus they did not support the hypothesis that TG response to carbohydrate loa- Table 1 . Clinical characteristics of the study groups ding may be excessive in MetS patients. The decrease in TG levels at OGTT hour 2 in this study was probably due to the acute reducing effect of early-phase insulin secretion in OGTT on TG, as it is known that early-phase insulin secretion may lead to increases in lipolysis inhibition and lipoprotein lipase activity (17) . Therefore, the peak OGTT 1-hour insulin levels, in parallel with glucose levels and the significant decrease in 2-hour insulin levels, support this finding. In this study, we determined OGTT 2-hour TG levels to be significantly correlated to parameters associated with insulin resistance, such as fasting blood glucose, waist circumference, HDL-C, TG/HDL-C, insulin, and HOMA-IR, in patients with MetS. This finding supports the idea that TG levels are associated with insulin resistance among MetS patients (1).
Study Limitations
The selection of enrolled patients among the prediabetic cases in terms of OGTT indication may be a limitation. Having healthy control subjects could lead to a better interpretation of the results, but administering OGTT to a healthy group is not part of common practice. In addition, patients with NGT and IGT are evaluated together in our study and the combined interpretation of these two groups may constitute a limitation. However, the incidence of NGT and IGT patients in both the MetS and control groups was found to be similar, which may also nullify this limitation.
CONCLUSION
The results of the present study did not support the hypothesis that response may be excessive among MetS patients following 
